Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

Absence of cardiac toxicity of zidovudine in infants. Pediatric Pulmonary and Cardiac Complications of Vertically Transmitted HIV Infection Study Group.

Lipshultz SE, Easley KA, Orav EJ, Kaplan S, Starc TJ, Bricker JT, Lai WW, Moodie DS, Sopko G, McIntosh K, Colan SD.

N Engl J Med. 2000 Sep 14;343(11):759-66.

2.

Perinatal exposure to zidovudine--benefits and risks.

Mofenson LM.

N Engl J Med. 2000 Sep 14;343(11):803-5. No abstract available.

PMID:
10984571
3.

Lack of long-term effects of in utero exposure to zidovudine among uninfected children born to HIV-infected women. Pediatric AIDS Clinical Trials Group Protocol 219/076 Teams.

Culnane M, Fowler M, Lee SS, McSherry G, Brady M, O'Donnell K, Mofenson L, Gortmaker SL, Shapiro DE, Scott G, Jimenez E, Moore EC, Diaz C, Flynn PM, Cunningham B, Oleske J.

JAMA. 1999 Jan 13;281(2):151-7.

PMID:
9917118
4.

Alterations in cardiac and pulmonary function in pediatric rapid human immunodeficiency virus type 1 disease progressors. Pediatric Pulmonary and Cardiovascular Complications of Vertically Transmitted Human Immunodeficiency Virus Study Group.

Shearer WT, Lipshultz SE, Easley KA, McIntosh K, Pitt J, Quinn TC, Kattan M, Goldfarb J, Cooper E, Bryson Y, Kovacs A, Bricker JT, Peavy H, Mellins RB, Heart N, Institute LB.

Pediatrics. 2000 Jan;105(1):e9.

5.

Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group.

Connor EM, Sperling RS, Gelber R, Kiselev P, Scott G, O'Sullivan MJ, VanDyke R, Bey M, Shearer W, Jacobson RL, et al.

N Engl J Med. 1994 Nov 3;331(18):1173-80.

6.

Cardiac structure and function in children with human immunodeficiency virus infection treated with zidovudine.

Lipshultz SE, Orav EJ, Sanders SP, Hale AR, McIntosh K, Colan SD.

N Engl J Med. 1992 Oct 29;327(18):1260-5.

7.

Pregnancy and infant outcomes among HIV-infected women taking long-term ART with and without tenofovir in the DART trial.

Gibb DM, Kizito H, Russell EC, Chidziva E, Zalwango E, Nalumenya R, Spyer M, Tumukunde D, Nathoo K, Munderi P, Kyomugisha H, Hakim J, Grosskurth H, Gilks CF, Walker AS, Musoke P; DART trial team.

PLoS Med. 2012;9(5):e1001217. doi: 10.1371/journal.pmed.1001217. Epub 2012 May 15.

8.

Cardiac effects of antiretroviral therapy in HIV-negative infants born to HIV-positive mothers: NHLBI CHAART-1 (National Heart, Lung, and Blood Institute Cardiovascular Status of HAART Therapy in HIV-Exposed Infants and Children cohort study).

Lipshultz SE, Shearer WT, Thompson B, Rich KC, Cheng I, Orav EJ, Kumar S, Pignatelli RH, Bezold LI, LaRussa P, Starc TJ, Glickstein JS, O'Brien S, Cooper ER, Wilkinson JD, Miller TL, Colan SD.

J Am Coll Cardiol. 2011 Jan 4;57(1):76-85. doi: 10.1016/j.jacc.2010.08.620.

9.

In utero exposure to zidovudine and heart anomalies in the ANRS French perinatal cohort and the nested PRIMEVA randomized trial.

Sibiude J, Le Chenadec J, Bonnet D, Tubiana R, Faye A, Dollfus C, Mandelbrot L, Delmas S, Lelong N, Khoshnood B, Warszawski J, Blanche S; French National Agency for Research on AIDS and Viral Hepatitis French Perinatal Cohort/Protease Inhibitor Monotherapy Evaluation Trial.

Clin Infect Dis. 2015 Jul 15;61(2):270-80. doi: 10.1093/cid/civ260. Epub 2015 Apr 1.

10.

Zidovudine therapy and left ventricular function and mass in human immunodeficiency virus-infected patients.

Cardoso JS, Moura B, Mota-Miranda A, Gonçalves FR, Lecour H.

Cardiology. 1997 Jan-Feb;88(1):26-8.

PMID:
8960621
11.

Absence of cardiac toxicity of zidovudine in infants.

Lewis W.

N Engl J Med. 2001 Feb 8;344(6):458. No abstract available.

12.

Antiretroviral exposure and lymphocyte mtDNA content among uninfected infants of HIV-1-infected women.

Aldrovandi GM, Chu C, Shearer WT, Li D, Walter J, Thompson B, McIntosh K, Foca M, Meyer WA 3rd, Ha BF, Rich KC, Moye J Jr.

Pediatrics. 2009 Dec;124(6):e1189-97. doi: 10.1542/peds.2008-2771. Epub 2009 Nov 23.

13.

Growth of human immunodeficiency virus-uninfected children exposed to perinatal zidovudine for the prevention of mother-to-child human immunodeficiency virus transmission.

Briand N, Le Coeur S, Traisathit P, Karnchanamayul V, Hansudewechakul R, Ngampiyasakul C, Bhakeecheep S, Ithisukanan J, Hongsiriwon S, McIntosh K, Lallemant M.

Pediatr Infect Dis J. 2006 Apr;25(4):325-32.

PMID:
16567984
14.

Abbreviated regimens of zidovudine prophylaxis and perinatal transmission of the human immunodeficiency virus.

Wade NA, Birkhead GS, Warren BL, Charbonneau TT, French PT, Wang L, Baum JB, Tesoriero JM, Savicki R.

N Engl J Med. 1998 Nov 12;339(20):1409-14.

15.

Breastfeeding plus infant zidovudine prophylaxis for 6 months vs formula feeding plus infant zidovudine for 1 month to reduce mother-to-child HIV transmission in Botswana: a randomized trial: the Mashi Study.

Thior I, Lockman S, Smeaton LM, Shapiro RL, Wester C, Heymann SJ, Gilbert PB, Stevens L, Peter T, Kim S, van Widenfelt E, Moffat C, Ndase P, Arimi P, Kebaabetswe P, Mazonde P, Makhema J, McIntosh K, Novitsky V, Lee TH, Marlink R, Lagakos S, Essex M; Mashi Study Team.

JAMA. 2006 Aug 16;296(7):794-805.

PMID:
16905785
16.

Hematological effects of zidovudine prophylaxis in newborn infants with and without prenatal exposure to zidovudine.

Baroncelli S, Pinnetti C, Genovese O, Tamburrini E, Floridia M.

J Med Virol. 2011 Mar;83(3):551-6. doi: 10.1002/jmv.21986.

PMID:
21264878
17.

Single-dose perinatal nevirapine plus standard zidovudine to prevent mother-to-child transmission of HIV-1 in Thailand.

Lallemant M, Jourdain G, Le Coeur S, Mary JY, Ngo-Giang-Huong N, Koetsawang S, Kanshana S, McIntosh K, Thaineua V; Perinatal HIV Prevention Trial (Thailand) Investigators.

N Engl J Med. 2004 Jul 15;351(3):217-28. Epub 2004 Jul 9.

18.

Missed opportunities for perinatal HIV prevention among HIV-exposed infants born 1996-2000, pediatric spectrum of HIV disease cohort.

Peters V, Liu KL, Dominguez K, Frederick T, Melville S, Hsu HW, Ortiz I, Rakusan T, Gill B, Thomas P.

Pediatrics. 2003 May;111(5 Pt 2):1186-91.

PMID:
12728136
19.

Neonatal predictors of infection status and early death among 332 infants at risk of HIV-1 infection monitored prospectively from birth. New York City Perinatal HIV Transmission Collaborative Study Group.

Abrams EJ, Matheson PB, Thomas PA, Thea DM, Krasinski K, Lambert G, Shaffer N, Bamji M, Hutson D, Grimm K, et al.

Pediatrics. 1995 Sep;96(3 Pt 1):451-8.

PMID:
7651777
20.

Cardiac effects of in-utero exposure to antiretroviral therapy in HIV-uninfected children born to HIV-infected mothers.

Lipshultz SE, Williams PL, Zeldow B, Wilkinson JD, Rich KC, van Dyke RB, Seage GR 3rd, Dooley LB, Kaltman JR, Siberry GK, Mofenson LM, Shearer WT, Colan SD; Pediatric HIVAIDS Cohort Study (PHACS).

AIDS. 2015 Jan 2;29(1):91-100. doi: 10.1097/QAD.0000000000000499.

Items per page

Supplemental Content

Write to the Help Desk